U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570121) titled 'Pharmacokinetics and Placental Transfer of Caffeine' on April 21.
Brief Summary: The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffeine will be given to each pregnant participant before delivery. Blood will be drawn to measure caffeine levels in the pregnant mother. Blood will also be taken from the placenta and from the newborn to measure caffeine levels. This data will be used to form a computer model of the metabolism of caffeine during pregnancy.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Preter...